Breast cancer research : BCR · 2026
Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ding Yan, Yu Juan, Liu Min, Liu Xiangyu, Kang Ling, Huang Liujing, Li Jinze, Wang Yanan, Xu Xin, Zhao Min, Wei Ping, Li Shuangbiao, Li Zaibo, Liu Yueping
Аннотация
BACKGROUND: Neoadjuvant therapy (NAT) is crucial for locally advanced breast cancer, but post-NAT lymph node assessment is challenging due to histological changes. Current methods like immunohistochemistry (IHC) are labor-intensive and imprecise in distinguishing isolated tumor cells (ITCs), micro-metastases (Micro), and macro-metastases (Macro). We aimed to develop and validate an AI-driven model for precise classification of lymph node metastasis status (negative, ITC, Micro, Macro) in breast cancer patients post-NAT.
METHODS: We used a weakly supervised Clustering-constrained Attention Multiple Instance Learning (CLAM) framework to analyze 7764 lymph node samples from 7 cohorts. The CLAM model identifies high-diagnostic-value subregions within whole-slide images (WSIs) and generates high-resolution interpretability heatmaps. Performance was evaluated using binary and multi-class metrics, with external validation on diverse datasets. A human-AI comparative analysis was conducted on 24 patient-derived lymph node sections.
RESULTS: The AI model achieved an AUROC of 0.97 (95% CI: 0.962-0.977) in binary classification and an overall accuracy of 0.8436 (95% CI: 0.8282-0.8562) for multi-class differentiation. In the human-AI comparison, the model outperformed junior pathologists, reducing diagnostic discrepancies by 83%.
CONCLUSION: This study establishes a robust AI model that significantly improves the accuracy and efficiency of post-NAT lymph node metastasis assessment in breast cancer, automating classification and reducing pathologist workload.
METHODS: We used a weakly supervised Clustering-constrained Attention Multiple Instance Learning (CLAM) framework to analyze 7764 lymph node samples from 7 cohorts. The CLAM model identifies high-diagnostic-value subregions within whole-slide images (WSIs) and generates high-resolution interpretability heatmaps. Performance was evaluated using binary and multi-class metrics, with external validation on diverse datasets. A human-AI comparative analysis was conducted on 24 patient-derived lymph node sections.
RESULTS: The AI model achieved an AUROC of 0.97 (95% CI: 0.962-0.977) in binary classification and an overall accuracy of 0.8436 (95% CI: 0.8282-0.8562) for multi-class differentiation. In the human-AI comparison, the model outperformed junior pathologists, reducing diagnostic discrepancies by 83%.
CONCLUSION: This study establishes a robust AI model that significantly improves the accuracy and efficiency of post-NAT lymph node metastasis assessment in breast cancer, automating classification and reducing pathologist workload.